首页> 外文OA文献 >Carvedilol increases the systemic bioavailability of oral digoxin.
【2h】

Carvedilol increases the systemic bioavailability of oral digoxin.

机译:卡维地洛可提高口服地高辛的全身生物利用度。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The effects of a single oral dose of 25 mg carvedilol on the plasma and urinary kinetics of digoxin after an oral and intravenous 0.5 mg dose, were investigated in two separate double-blind, placebo-controlled, period-balanced cross-over studies in healthy male subjects. Carvedilol increased the mean maximum plasma concentration and the area under the plasma concentration time-curve of digoxin when administered orally. The effects were virtually confined to the first 4 h after dosing, and the apparent terminal disposition rate constant was not changed. Carvedilol did not alter the plasma and urinary kinetics of intravenously administered digoxin.
机译:在两项健康独立的双盲,安慰剂对照,时间平衡交叉研究中,研究了单次口服25 mg卡维地洛对口服和静脉内0.5 mg剂量后地高辛的血浆和尿动力学的影响。男性对象。口服卡维地洛可增加地高辛的平均最大血浆浓度和血浆浓度时间曲线下的面积。作用实际上被限制在给药后的前4小时,并且表观的末端处置速率常数没有改变。卡维地洛不会改变静脉注射地高辛的血浆和尿动力学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号